184
Views
38
CrossRef citations to date
0
Altmetric
Original Research

Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population

, , , , , , & show all
Pages 735-744 | Published online: 23 Feb 2017

References

  • MiniñoAXuJKochanekKDeaths: preliminary data for 2008Natl Vital Stat Rep2010592152
  • FordESMurphyLBKhavjouOGilesWHHoltJBCroftJBTotal and state-specific medical and absenteeism costs of COPD among adults aged ≥18 years in the United States for 2010 and projections through 2020Chest20151471314525058738
  • AnderssonFBorgSJanssonSAThe costs of exacerbations in chronic obstructive pulmonary disease (COPD)Respir Med200296970070812243316
  • Global Initiative for Chronic Obstructive Lung Diseaseglobal Strategy for Diagnosis, Management and Prevention of COPD2015 Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2015_Feb18.pdfAccessed October 27, 2015
  • SmithMCWrobelJPEpidemiology and clinical impact of major comorbidities in patients with COPDInt J Chron Obstruct Pulmon Dis2014987188825210449
  • VanfleterenLESpruitMAGroenenMClusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2013187772873523392440
  • WierLElixhauserAPfuntnerAAuDOverview of Hospitalizations among Patients with COPD, 2008HCUP Statistical Brief #106National Vital Statistics ReportsRockville, MDAgency for Healthcare Research and Quality (US)2011
  • HolguinFFolchEReddSCManninoDMComorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001Chest200512842005201116236848
  • MenzinJBoulangerLMartonJThe economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare populationRespir Med200810291248125618620852
  • CullyJAGrahamDPStanleyMAQuality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depressionPsychosomatics200647431231916844889
  • NegewoNAGibsonPGMcDonaldVMCOPD and its comorbidities: impact, measurement and mechanismsRespirology20152081160117126374280
  • KingPTInflammation in chronic obstructive pulmonary disease and its role in cardiovascular disease and lung cancerClin Transl Med2015416826220864
  • Simon-TuvalTScharfSMMaimonNBernhard-ScharfBJReuveniHTarasiukADeterminants of elevated healthcare utilization in patients with COPDRespir Res201112721232087
  • Healthcare Cost and Utilization Project (HCUP) [webpage on the Internet]Clinical Classifications Software (CCS) for ICD-9-CM Available from: http://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jspAccessed August 2013
  • DeyoRACherkinDCCiolMAAdapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJ Clin Epidemiol19924566136191607900
  • CavaillèsABrinchault-RabinGDixmierAComorbidities of COPDEur Respir Rev20132213045447524293462
  • HansonCRuttenEWoutersERennardSInfluence of diet and obesity on COPD development and outcomesInt J Chron Obstruct Pulmon Dis2014972373325125974
  • LaurinCMoullecGBaconSLavoieKImpact of anxiety and depression on chronic obstructive pulmonary disease exacerbation riskAm J Respir Crit Care Med2012185991892322246177
  • RusinaruDSaaidiIGodardSMahjoubHBattleCTribouilloyCImpact of chronic obstructive pulmonary disease on long-term outcome of patients hospitalized for heart failureAm J Cardiol2008101335335818237599
  • FearyJRRodriguesLCSmithCJHubbardRBGibsonJEPrevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary careThorax2010651195696220871122
  • YoshizawaTOkadaKFuruichiSPrevalence of chronic kidney diseases in patients with chronic obstructive pulmonary disease: assessment based on glomerular filtration rate estimated from creatinine and cystatin C levelsInt J Chron Obstruct Pulmon Dis2015101283112826185434
  • LehouckABoonenSDecramerMJanssensWCOPD, bone metabolism, and osteoporosisChest2011139364865721362651
  • WeitzenblumEChaouatAKesslerRCanuetMOverlap syndrome: obstructive sleep apnea in patients with chronic obstructive pulmonary diseaseProc Am Thorac Soc20085223724118250217
  • ChaouatAWeitzenblumEKriegerJPrognostic value of lung function and pulmonary haemodynamics in OSA patients treated with CPAPEur Respir J19991351091109610414409
  • Bureau of Labor Statistics [homepage on the Internet] Available from: https://www.bls.gov/data/Accessed December 22, 2016
  • SloanKLSalesAELiuCFConstruction and characteristics of the RxRisk-V: a VA-adapted pharmacy-based case-mix instrumentMed Care200341676177412773842
  • Centers for Disease Control and Prevention (CDC)Behavioral Risk Factor Surveillance System Survey DataAtlanta, GAU.S. Department of Health and Human Services, Centers for Disease Control and Prevention2011
  • MapelDWDutroMPMartonJPWoodruffKMakeBIdentifying and characterizing COPD patients in US managed care. A retrospective, cross-sectional analysis of administrative claims dataBMC Health Serv Res2011114321345188
  • LinPJShayaFTScharfSMEconomic implications of comorbid conditions among Medicaid beneficiaries with COPDRespir Med2010104569770419954941
  • DalalAAShahMLunacsekOHananiaNAClinical and economic burden of depression/anxiety in chronic obstructive pulmonary disease patients within a managed care populationCOPD20118429329921827298
  • MapelDWMcMillanGPFrostFJPredicting the costs of managing patients with chronic obstructive pulmonary diseaseRespir Med200599101325133316140232
  • Centers for Disease Control and PreventionChronic obstructive pulmonary disease among adults – United States, 2011MMWR Morb Mortal Wkly Rep2012614693894323169314